Tibicorten and betamethasone valerate: a double-blind comparative study

J Int Med Res. 1977;5(5):338-45. doi: 10.1177/030006057700500509.

Abstract

Tibicorten, a new fluorine-substituted corticosteroid for topical application, was compared with betamethasone valerate in a double-blind investigation with left-right examinations. There appeared to be no significant difference between the results obtained with each substance in the treatment of patients with acute or chronic eczema or with psoriasis.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Betamethasone / analogs & derivatives*
  • Betamethasone Valerate / therapeutic use*
  • Child
  • Chronic Disease
  • Clinical Trials as Topic
  • Eczema / drug therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Psoriasis / drug therapy*
  • Triamcinolone Acetonide / analogs & derivatives*
  • Triamcinolone Acetonide / therapeutic use

Substances

  • Betamethasone
  • triamcinolone benetonide
  • Betamethasone Valerate
  • Triamcinolone Acetonide